As of January 22, 2025, Procaps Group (PROC) has a market cap of $0.19 billion USD. According to our data, Procaps Group is ranked No.7150 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.19 B |
-27.78%
|
Dec 31, 2024 | $0.26 B |
-42.51%
|
Dec 29, 2023 | $0.46 B |
-22.48%
|
Dec 30, 2022 | $0.59 B |
-46.15%
|
Dec 31, 2021 | $1.10 B |
-6.25%
|
Dec 31, 2020 | $1.17 B |
5.58%
|
Dec 31, 2019 | $1.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Catalent
CTLT
|
$11.52 B |
0.000 M
|
USA
|
Lonza
LONN.SW
|
$46.05 B |
0.669 B
|
Switzerland
|
Lonza
LONN.SW
|
$46.05 B |
0.669 B
|
Switzerland
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Perrigo
PRGO
|
$3.28 B |
0.000 M
|
Ireland
|
Barclays
BCS
|
$52.13 B |
-0.002 M
|
UK
|
Fresenius
FRE.DE
|
$21.06 B |
0.001 M
|
Germany
|
Aurobindo Pharma
AUROPHARMA.NS
|
$8.01 B |
32.249 M
|
India
|
Sun Pharmaceutical
SUNPHARMA.NS
|
$49.93 B |
1.006 B
|
India
|
Cipla
CIPLA.NS
|
$13.45 B |
0.107 B
|
India
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Market Cap | = | PROC Stock Price | * | PROC Shares Outstanding |
= | $1.69 | * | 0.11 B | |
= | $0.19 B |